A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.

Blockmans D, Penn SK, Setty AR, Schmidt WA, Rubbert-Roth A, Hauge EM, Keen HI, Ishii T, Khalidi N, Dejaco C, Cid MC, Hellmich B, Liu M, Zhao W, Lagunes I, Romero AB, Wung PK, Merkel PA; SELECT-GCA Study Group. N Engl J Med. 2025 Apr 2. PMID: 40174237